Literature DB >> 6443852

Expression of HLA-DR by a human monocyte cell line is under transcriptional control.

B M Peterlin1, T A Gonwa, J D Stobo.   

Abstract

Several studies have demonstrated that the expression of Ia molecules by macrophages is not constitutive but can be enhanced by soluble factors from activated T cells. This induced expression of Ia appears to be causally important in certain accessory functions such as antigen presentation. While the phenomenon of Ia induction is clear, the mechanism by which this occurs has not been determined. Therefore, experiments were designed to investigate the molecular events leading to expression of the human Ia molecule, HLA-DR. To accomplish this, the human monocytoid cell line U 937, which does not express any detectable HLA-DR molecules were used. Utilizing a cDNA probe for the alpha chain of HLA-DR and total cellular RNA, it could be demonstrated that resting U 937 lacked detectable HLA-DR transcripts. Digestion of genomic DNA from U 937 with the isoschizomers Msp I and Hpa II followed by analysis of the restriction fragments on Southern blots demonstrated the HLA-DR alpha chain genes to be methylated. Addition of 5-azacytidine, an analogue of cytidine which causes hypomethylation of DNA to U 937 caused hypomethylation of HLA-DR alpha chain genes but did not, by itself, lend to the appearance of HLA-DR molecules or transcripts. However, treatment of U 937 with 5-azacytidine followed by addition of either culture fluids from activated T cells or human recombinant gamma interferon did lead to the rapid appearance of abundant, mature HLA-DR transcripts and surface HLA-DR molecules. The results of these studies provide the first demonstration that methylation plays a role in the expression of human Ir genes and that induced expression of Ia molecules by soluble factors from T cells, including gamma interferon, is accompanied by the rapid appearance of Ir gene transcripts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6443852

Source DB:  PubMed          Journal:  J Mol Cell Immunol        ISSN: 0724-6803


  15 in total

1.  Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability.

Authors:  J S Passmore; R H Glashoff; P T Lukey; S R Ress
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 2.  Transcriptional regulation of HLA class-II genes.

Authors:  B M Peterlin; G Andersson; E Lötscher; S Tsang
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Hypomethylation of MHC class II Eb gene is associated with expression.

Authors:  T Scholl; A Pitcock; B Jones
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

4.  Evidence for methylation as a regulatory mechanism in HLA-DR alpha gene expression.

Authors:  M N Carrington; R D Salter; P Cresswell; J P Ting
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Methylation patterns of HLA-DR alpha genes in six mononuclear cell lines.

Authors:  Y Wang; B M Peterlin
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Differential effect of cyclosporin A on activation signaling in human T cell lines.

Authors:  B Manger; K J Hardy; A Weiss; J D Stobo
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

7.  Methylation of the HLA-DR alpha gene is positively correlated with expression.

Authors:  J S Lee; L O'Neill
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

8.  Differential expression of Ia molecules by human monocytes.

Authors:  T A Gonwa; J D Stobo
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

9.  Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.

Authors:  X D Fan; M Goldberg; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

Authors:  M A Blanar; E C Boettger; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.